NCT01815710 Best Strategies for Implementation of Clinical Pathways in Emergency Department Settings Status COMPLETED Phase N/A
NCT01813084 A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of RV1729 Status COMPLETED Phase PHASE1
NCT01808339 To Investigate the Effects of Altering the Time of Day of Dosing (Morning or Evening) With Fluticasone Furoate 100 Micrograms Once Daily Administered Via a Dry Powder Inhaler in Subjects With Asthma Status COMPLETED Phase PHASE2
NCT01805635 PF and FeNO and Clinical Characteristics in Children Being Diagnosed Due to Suspicion of Allergic Diseases Status UNKNOWN Phase N/A
NCT01803555 Efficacy and Safety Evaluation of Budesonide/Formoterol SPIROMAX® Inhalation Powder Versus SYMBICORT® TURBOHALER® Status COMPLETED Phase PHASE3
NCT01803087 Single-Dose Clinical Pharmacology Study in Asthmatic Adolescent and Adult Patients Status COMPLETED Phase PHASE2
NCT01799746 Mechanisms of Response to Diesel Exhaust in Subjects With Asthma Status WITHDRAWN Phase N/A
NCT01795742 Equivalence of a Human-Powered Nebulizer to an Electric Nebulizer Status COMPLETED Phase PHASE2
NCT01795664 Compare the Effects of Seretide® Evohaler and a Generic Salmeterol/Fluticasone Hydrofluoroalkane (HFA) Pressurized Metered-dose Inhaler (pMDI) on Functional Respiratory Imaging Parameters in Asthmatic Patients Status COMPLETED Phase PHASE3
NCT01793298 Safety, Tolerability and Pharmacokinetics of ASM-024 Administered to Healthy Subjects and Subjects With Moderate Asthma Status TERMINATED Phase PHASE1/PHASE2
NCT01786616 Polymorphism of beta2-adrenoceptor and Regular Use of Formoterol in Asthma Status COMPLETED Phase N/A
NCT01785901 The Asthma Control Rate Achieved by Budesonide/Formoterol in Clinical Practice in China Status COMPLETED Phase N/A
NCT01785017 The Effects of a Standardized Management Plan on Children With Critical Asthma Status COMPLETED Phase N/A